WNT5A, a typical glycoprotein of the non-canonical pathway, has been verified to have pro-inflammatory functions in urosepsis, nephrogenic diabetes insipidus (NDI), and chronic kidney disease (CKD) (28–30). Here, WNT5A is linked to chronic kidney disease.